ATPC Agape ATP Corporation Net earnings per share for the last 12 months

Public company logo of agapeatpgroup.com (ATPC)

Agape ATP Corporation (ATPC) is undergoing a demand stabilization phase for preventive medicine in Asia. The company's net profit per share over 12 months on the GURU.Markets chart reflects this trend, where the value -1.22 represents the current metric. While the firm is expanding partnerships with medical centers through personalized nutrition, its micro-cap status and lack of a technological edge hinder the generation of a stable cash flow.

ATPC (Agape ATP Corp.) Net earnings per share (EPS TTM) history from 02/21/2024 to 11/16/2026

Analytical breakdowns and data insights for company Agape ATP Corporation (ATPC)

- stock price and consensus target price:
Fundamental company valuation:Agape ATP Corporation (ATPC)
Mass-produced product of Agape ATP Corp.

EPS TTM measures the actual earnings per share over a rolling year, neutralizing quarterly reporting gaps. Investors assess capital management efficiency through the dynamics of this value. By analyzing the trend of annual net income per share, one can identify hidden profitability cycles. For Agape ATP Corporation (ATPC), the volatility of the line confirms unstable sales within the dietary supplement sector. The lack of business scale makes this indicator a critical marker in the absence of a sustainable cash flow.

Competitors of Agape ATP Corporation

Ascendis - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Madrigal Pharma|CORT (Corcept Therapeutics Incorporated) - Net earnings per share for the last 12 months|RYTM: Earnings per share for the last four quarters|AKRO (Akero Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Metsera Inc|Net earnings per share (EPS TTM) MLTX|Earnings per share for the last twelve months CRNX (Crinetics Pharmaceuticals, Inc.)|Earnings per share for the last twelve months newamsterdampharma.com NAMS|Soleno Therapeutics Corp (SLNO) - Net earnings per one share for the last twelve months|FOLD - Earnings per share for the last twelve months|ETNB: Earnings per share for the last twelve months|AGIO: Net earnings per share (EPS TTM)|GPCR - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MiMedx Corp|Rezolute Bio (RZLT) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months lexpharma.com (LXRX)|Net earnings per share for the last 12 months MBX Biosciences Inc MBX|Earnings per share for the last twelve months Altimmune ALT|Net earnings per share (EPS TTM) Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters BioAge Labs, Inc BIOA|Biomea Fusion Inc (BMEA) - Earnings per share for the last twelve months|QNCX - Net earnings per share for the last four quarters|GUTS (Fractyl Health Inc.) - Net earnings per share (EPS TTM)|VTVT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLUR|SYBX - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) LPCN (lipocine.com)|Net earnings per share (EPS TTM) Matinas BioPharma MTNB|SPRB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months Galecto Corp|CTCX (Carmell Corp) - Net earnings per share for the last 12 months|Lumos Pharma Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months ONVO|Net earnings per one share for the last twelve months Radius Recycling, Inc. RDUS